William DeVaul

Consigliere Generale presso MORPHIC HOLDING, INC.

Patrimonio netto: 644 351 $ in data 30/04/2024

53 anni

Health Technology

Consumer Services

Posizioni attive di William DeVaul

Società	Posizione	Inizio	Fine
MORPHIC HOLDING, INC.	Consigliere Generale	01/02/2019	-
MORPHIC HOLDING, INC.	Segretario Aziendale	01/02/2019	-
Morphic Therapeutic, Inc. Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA.	Consigliere Generale	-	-
	Segretario Aziendale	-	-

Società	Posizione	Inizio	Fine
EVELO BIOSCIENCES, INC.	Corporate Officer/Principal	01/05/2015	01/02/2019
CUBIST PHARMACEUTICALS INC	Corporate Officer/Principal	01/01/2003	01/02/2015

Boston University School of Law	Graduate Degree
The Trustees of Columbia University in The City of New York	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	2
General Counsel	2
Corporate Secretary	2

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
EVELO BIOSCIENCES, INC.	Health Technology
MORPHIC HOLDING, INC.	Health Technology

Aziende private	2
Morphic Therapeutic, Inc. Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA.	Health Technology
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA.	Health Technology